Patents by Inventor Lance Elliott Schlipalius

Lance Elliott Schlipalius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carotenoid composition
    Patent number: 6132790
    Abstract: The invention is to a carotenoid composition comprising:a) a carotenoid in an oil solvent wherein the weight of carotenoid in the carotenoid composition is up to 12%;b) a dispersion of a water dispersible matrix and a stabilizer, and optionally a non-oil solvent; andc) an emulsifier,wherein the carotenoid, non-oil solvent, water dispersible matrix, stabilizer and emulsifier all either exist naturally or are derived from natural sources without the use of chemical or synthesized compounds, nor chemically modified using processes of synthetic chemistry.
    Type: Grant
    Filed: November 5, 1996
    Date of Patent: October 17, 2000
    Assignee: Betatene Limited
    Inventor: Lance Elliott Schlipalius
  • Therapeutic agent for the treatment of melanomas
    Patent number: 5897871
    Abstract: The present invention provides a therapeutic agent for the treatment of a melanoma or melanomas by injection or intravenously including a mixture of: (a) a water soluble dispersible component; (b) an emulsifier component; and (c) a water insoluble carotenoid component in a suitable carrier medium.
    Type: Grant
    Filed: August 7, 1997
    Date of Patent: April 27, 1999
    Assignee: Betatine Limited
    Inventor: Lance Elliott Schlipalius
  • Aqueous formulations of water-insoluble therapeutic agent comprising carotenoids and/or tocopherols
    Patent number: 5773026
    Abstract: The invention is a carotenoid agent for inhibiting the conversion of epithelial cells to tumours, the agent including an effective amount of a water insoluble carotenoid component in a suitable non-toxic carrier medium.
    Type: Grant
    Filed: September 22, 1995
    Date of Patent: June 30, 1998
    Assignee: Betatene Limited
    Inventor: Lance Elliott Schlipalius
  • Therapeutic agent for the treatment of melanomas
    Patent number: 5705180
    Abstract: The present invention provides a therapeutic agent for the treatment of a melanoma or melanomas by injection or intravenously including a mixture of: (a) a water soluble dispersible component; (b) an emulsifier component; and (c) a water insoluble carotenoid component in a suitable carrier medium.
    Type: Grant
    Filed: September 22, 1995
    Date of Patent: January 6, 1998
    Assignee: Betatene Limited
    Inventor: Lance Elliott Schlipalius